MarketCap
Facebook
X
TelegramGenMark Diagnostics, Inc. Retained Earnings 2011-2026 | GNMK
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings GenMark Diagnostics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -533 M | -514 M | -467 M | -417 M | -355 M | -305 M | -262 M | -224 M | -191 M | -168 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -168 M | -533 M | -344 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.48 B | $ 174.53 | -1.3 % | $ 13.1 B |  USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 11.07 | -5.06 % | $ 1.66 B | USA |
 |
Bio-Rad Laboratories
BIO
|
7.42 B | $ 277.5 | -1.3 % | $ 7.83 B | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.22 | 0.33 % | $ 1.65 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-63.5 M | $ 3.36 | -0.3 % | $ 126 M |  France |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 37.98 | -0.71 % | $ 5.66 K | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.6 | -2.45 % | $ 37.3 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 61.28 | -2.05 % | $ 90.7 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 8.96 | -2.29 % | $ 254 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 24.41 | 0.04 % | $ 206 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
1.39 B | $ 91.4 | -0.61 % | $ 12.4 B | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.15 | 0.24 % | $ 878 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.88 | 0.3 % | $ 354 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Inogen
INGN
|
-176 M | $ 6.66 | -0.15 % | $ 177 M | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 56.69 | 6.2 % | $ 1.66 B | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.93 | 0.93 % | $ 1.15 B | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.04 | 0.97 % | $ 17.6 M | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 86.67 | -0.93 % | $ 3.01 B | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.61 | -0.05 % | $ 122 M | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 79.15 | -3.13 % | $ 46.3 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.94 | -0.44 % | $ 374 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 1.89 | 0.53 % | $ 1.15 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 63.37 | -2.0 % | $ 3.46 B |  Britain |
 |
LENSAR
LNSR
|
-178 M | $ 5.46 | -1.27 % | $ 65.3 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |